Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women

Variant 2: Newly diagnosed. Stage I breast cancer. Asymptomatic. Rule out thoracic metastases. Initial imaging. The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.

[1]  Linda Moy,et al.  Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. , 2018, Journal of the American College of Radiology : JACR.

[2]  W. Moon,et al.  Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy , 2017, JAMA oncology.

[3]  A. G. García Vicente,et al.  18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[4]  S. Edge,et al.  Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[5]  N. Lin,et al.  Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often? , 2017, Breast.

[6]  Andriy I Bandos,et al.  Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. , 2014, Radiology.

[7]  Andriy I Bandos,et al.  Comparison of two-dimensional synthesized mammograms versus original digital mammograms alone and in combination with tomosynthesis images. , 2014, Radiology.

[8]  Rachel V. Stankowski,et al.  Mammography utilization: patient characteristics and breast cancer stage at diagnosis. , 2013, AJR. American journal of roentgenology.

[9]  T. Riall,et al.  Quality of post-treatment surveillance of early stage breast cancer in Texas. , 2013, Surgery.

[10]  H. Pan,et al.  The Adjunctive Digital Breast Tomosynthesis in Diagnosis of Breast Cancer , 2013, BioMed research international.

[11]  E. Winer,et al.  International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. , 2013, Breast.

[12]  R. Hendrick,et al.  Combination of one-view digital breast tomosynthesis with one-view digital mammography versus standard two-view digital mammography: per lesion analysis , 2013, European Radiology.

[13]  KathleenR. Brandt,et al.  Can digital breast tomosynthesis replace conventional diagnostic mammography views for screening recalls without calcifications? A comparison study in a simulated clinical setting. , 2013, AJR. American journal of roentgenology.

[14]  C. Waldherr,et al.  Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening. , 2013, AJR. American journal of roentgenology.

[15]  N Houssami,et al.  Application of breast tomosynthesis in screening: incremental effect on mammography acquisition and reading time. , 2012, The British journal of radiology.

[16]  C. Flowers,et al.  Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. , 2012, Radiology.

[17]  D. Kolarevic,et al.  Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients? , 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[18]  James Nagarajah,et al.  Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer , 2011, Acta radiologica.

[19]  W. Han,et al.  The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma , 2011, Breast Cancer Research and Treatment.

[20]  L. Liberman,et al.  Breast MRI screening of women with a personal history of breast cancer. , 2010, AJR. American journal of roentgenology.

[21]  R. Moineddin,et al.  Population-based longitudinal study of follow-up care for breast cancer survivors. , 2010, Journal of oncology practice.

[22]  S. Larson,et al.  Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Coyle,et al.  Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series , 2009, Breast Cancer Research and Treatment.

[24]  MD Wendie A. Berg,et al.  Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.

[25]  E. Rosato,et al.  Mammographic appearance of recurrent breast cancer after breast conservation therapy. , 2008, Academic radiology.

[26]  T. Lash,et al.  Mammography surveillance and mortality in older breast cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Winer,et al.  Surveillance testing among survivors of early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[29]  Thomas J. Smith,et al.  American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[31]  T. Lash,et al.  Reduced Mortality Rate Associated with Annual Mammograms after Breast Cancer Therapy , 2006, The breast journal.

[32]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[33]  Diego R. Martín,et al.  MR imaging of the liver. , 2005, Radiologic clinics of North America.

[34]  F Puglisi,et al.  Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  Dino Amadori,et al.  Staging of Breast Cancer: New Recommended Standard Procedure , 2002, Breast Cancer Research and Treatment.

[36]  M. Johnston,et al.  Baseline staging tests in primary breast cancer: a practice guideline. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[37]  M. Indelli,et al.  Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. , 1994, JAMA.

[38]  S. Ciatto,et al.  Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial , 1994 .

[39]  S. Ciatto,et al.  Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. , 1994, JAMA.

[40]  H. Brar,et al.  Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients. , 1993, American journal of surgery.

[41]  P. Hudgins,et al.  Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. , 1991, AJNR. American journal of neuroradiology.

[42]  P. Robertson,et al.  Perceptions of Follow‐Up Care in Women with Breast Cancer , 1991, American journal of clinical oncology.

[43]  K. Zedeler,et al.  The value of yearly chest X-ray in patients with stage I breast cancer. , 1989, European journal of cancer & clinical oncology.

[44]  O. Salazar,et al.  Breast Cancer: Metastatic Patterns and Their Prognosis , 1988, Southern medical journal.

[45]  R. Rubens,et al.  Reappraisal of the baseline bone scan in breast cancer. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  S. Ciatto,et al.  Preoperative staging of primary breast cancer. A multicentric study , 1988, Cancer.

[47]  J. Thigpen,et al.  Preoperative evaluation with radionuclide brain scanning and computerized axial tomography of the brain in patients with breast cancer. , 1988, American journal of surgery.

[48]  M. Norusis,et al.  Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging. , 1987, Radiology.

[49]  L. Balducci,et al.  Evaluation of Bone Scan as a Screening Work‐up in Primary and Local‐Regional Recurrence of Breast Cancer , 1987, American journal of clinical oncology.

[50]  J. Ferrucci Leo J. Rigler lecture. MR imaging of the liver. , 1986, AJR. American journal of roentgenology.

[51]  L. Weisberg The computed tomographic findings in intracranial metastases due to breast carcinoma. , 1986, Computerized radiology : official journal of the Computerized Tomography Society.

[52]  B. McNeil,et al.  Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. , 1978, Surgery, gynecology & obstetrics.

[53]  M. Muslumanoglu,et al.  Surveillance of Patients Following Primary Therapy , 2019, Breast Disease.

[54]  Chad A. LaGrange,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[55]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[56]  A. Stuckey,et al.  ACR Appropriateness Criteria® Breast Cancer Screening. , 2017, Journal of the American College of Radiology : JACR.

[57]  K. Simpson Choosing Wisely. , 2016, MCN. The American journal of maternal child nursing.

[58]  E. Rutgers,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  Pragya A. Dang,et al.  Addition of tomosynthesis to conventional digital mammography: effect on image interpretation time of screening examinations. , 2014, Radiology.

[60]  B. Edel Marie Quinn MB,et al.  Use of Magnetic Resonance Imaging in Detection of Breast Cancer Recurrence: A Systematic Review , 2012, Annals of Surgical Oncology.

[61]  A. Liberati,et al.  Follow-up strategies for women treated for early breast cancer. , 2005, The Cochrane database of systematic reviews.

[62]  M. Ferro,et al.  Stage I Breast Cancer , 2002 .

[63]  D. Palli,et al.  It is now the age to define the appropriate follow-up of primary breast cancer patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  J. Brockschmidt,et al.  Postoperative follow‐up of patients with early breast cancer. Patterns of care among clinical oncologists and a review of the literature , 1991, Cancer.

[65]  M Brant-Zawadzki,et al.  MR imaging of the brain. , 1988, Radiology.

[66]  A. Rodger,et al.  Bone scintigraphy in breast cancer: a nine-year follow-up. , 1985, Clinical radiology.

[67]  F. Esposito,et al.  Comparison of CT scanning and radionuclide imaging in liver disease. , 1980, Critical reviews in diagnostic imaging.

[68]  Yeh Hc,et al.  Ultrasonography and computed tomography of the liver. , 1979, Progress in liver diseases.